No Morning After Blues for Barr Pharmaceuticals as 2007 Plan B Sales top $80 Million
No Morning After Blues for Barr Pharmaceuticals as 2007 Plan B Sales top $80 Million
Attachment: Barr Completed and Active Capital/MRO Projects Chart
Barr is most well known within the industry for its generic products, waging and winning many a patent battle for the rights to manufacture and market copycat drugs - Includes a listing of Barr projects and plants
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.